This article has Open Peer Review reports available.
Knee hemarthrosis after arthroscopic surgery in an athlete with low factor XIII activity
© Tsujii et al.; licensee BioMed Central Ltd. 2012
Received: 9 November 2011
Accepted: 28 September 2012
Published: 2 October 2012
We report a thirteen-year-old tennis player with knee hemarthrosis caused by low factor XIII activity. She visited our hospital because of medial peripatellar pain for two years. Although there was no abnormal sign in X-ray or MRI, diagnostic arthroscopy was performed. It revealed some cartilage debris, medial plica and complete septum of suprapatellar plica. Removing the debris by washing out and resecting the medial plica, she could return to play tennis without perioperative symptom. Two months after the first operation, her knee got swelling without any apparent cause. Since 20 ml blood was aspirated twice and MRI revealed suprapatellar mass, we performed arthroscopy again. Suprapatellar mass was old blood clot covered with complete suprapatellar plica. Resection of suprapatellar plica and washing out blood clot were performed, and severe postoperative hemarthrosis was progressively occurred. As factor XIII level was 54% preoperatively, we diagnosed that this condition was caused by low activity level of the factor and administered factor XIII concentrates. The level got improved to 129% and then hemarthrosis gradually relieved. She had no signs of recurrence. We should keep in mind of low factor XIII activity case in case of unexplained postoperative hemarthrosis after arthroscopy because consumption of the factor might promote this condition.
Hemarthrosis is one of the most common complications after knee arthroscopy . Hemarthrosis is generally not severe except in coagulation factor deficiency. In case of hemophilia this complication is critical, and standard coagulation studies can reveal this disorder. But deficiency of factor XIII cannot be suggested with those studies. Therefore, it is necessary to test factor XIII activity or clot solubility test for diagnosing this disorder. Factor XIII is known as fibrin stabilizing factor, which acts in the terminal phase of the coagulation cascade. The disorder presents clinically with bleeding diathesis, and impaired wound healing. Congenital deficiency of factor XIII was first described in 1960 by Duckert  and acquired deficiency of the factor was also reported in some articles [3–5]. However, there are few literatures associated with deficiency of factor XIII especially in the field of orthopedic surgery . We here present a case of postoperative hemarthrosis caused by low activity level of this factor.
Changes of Hemoglobin (g/dl) and XIII activity (%)
XIII activity (%)
We presented a case of severe knee hemarthrosis after knee arthroscopy. Although hemarthrosis is one of the most common complications after knee arthroscopy , it is generally not severe and often relieved spontaneously, except in coagulation factor deficiency. In case of hemophilia, which deficit factor VIII or IX, this complication is critical, and preoperative standard coagulation studies can reveal this disorder. But deficiency of factor XIII cannot be suggested with the standard coagulation examination, including prothrombin time, partial prothrombin time, thrombin time, bleeding time, platelet count, and qualitative platelet function assays. Therefore, it is necessary to test factor XIII activity or clot solubility test for diagnosing this condition.
Factor XIII, also known as fibrin stabilizing factor, is an enzyme required for normal fibrin clot formation. It acts in the terminal phase of the coagulation cascade, after thrombin has converted fibrinogen to fibrin. In the absence of factor XIII a clot is easily soluble, so its deficiency leads to prolonged bleeding which is characteristically delayed 12–36 h after stop bleeding. Congenital deficiency of factor XIII was first described in 1960 by Duckert . The disorder presents clinically with bleeding diathesis, and impaired wound healing. And it is also reported about acquired deficiency of factor XIII, caused by formation of antibody or unknown reason [3–5]. According to the European data, the most common bleeding symptoms were subcutaneous bleeding, muscle hematoma, hemorrhage after surgery, hemarthrosis, and intracerebral bleeding . Decreased enzymatic activity of factor XIII was discussed as a cause of unexplained intraoperative and/or postoperative hematoma in abdominal, gynecological, plastic, and urological surgery and also recently in the field of neurosurgery . To the best of our knowledge, however, there were few literatures about periarticular hematoma due to factor XIII deficiency or decreased activity level of factor XIII during perioperative phase. In this present case, low activity level of the factor seemed to be the cause of unexplained bleeding. As its concentration was recovered by administering the factor XIII concentrates, it was highly unlikely that the condition was associated to autoimmune antibody. In addition to the preoperative low activity level, consumption of the factor was likely to aggravate bleeding diathesis. As described by Korte, acquired factor XIII deficiency in the perioperative setting might be frequent . Furthermore, Spahn demonstrated that blood loss could be reduced with administration of a single dose of factor XIII given within 15 min commencement of surgery .
As for perioperative level of factor XIII, no report has clearly revealed when we should administer factor XIII concentrates. In general, it is considered sufficient to keep 10% in small bleed, or 20-30% in muscle hematoma. But in severe bleeding case or major surgery, increasing use of the factor in the wound, it is recommended to keep 100% preoperatively . Gerlach et al. reported the average postoperative decrease in factor XIII was approximately 18% in the neurosurgery patients . Furthermore, they concluded the risk of postoperative hematoma is increased in patients with factor XIII < 60%. Taking the conclusion into account, the perioperative low activity level of factor XIII might have been the risk of the hemarthrosis following arthroscopy.
We report a case of postoperative hemarthrosis caused by low factor XIII activity. Decreased activity of the factor seemed to be the cause, and the consumption might have an effect on bleeding diathesis. We should be in careful about managing this condition perioperatively as coagulation factor activity can decrease by increasing consumption of the factor.
Written informed consent was obtained from the patient for publication this case report and the images.
We thank Dr. Chinen Yoshiaki (Hematologist, Kyoto Prefectural University of Medicine) for his helpful suggestions for this report.
- Small NC: Complications in arthroscopic surgery performed by experienced arthroscopists. Arthroscopy. 1988, 4: 215-221. 10.1016/S0749-8063(88)80030-6.View ArticlePubMedGoogle Scholar
- Duckert F, Jung E, Sherling DH: A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh. 1960, 5: 179-186.PubMedGoogle Scholar
- Gregory TF, Cooper B: Case report of an acquired factor XIII inhibitor: diagnosis and management. Proc (Bayl Univ Med Cent). 2006, 19: 221-223.Google Scholar
- Lim W, Moffat K, Hayward CP: Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency. J Thromb Haemost. 2004, 2: 1017-1019. 10.1111/j.1538-7836.2004.00728.x.View ArticlePubMedGoogle Scholar
- Ajzner E, Schlammadinger A, Kerényi A, Bereczky Z, Katona E, Haramura G, Boda Z, Muszbek L: Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood. 2009, 113: 723-725. 10.1182/blood-2008-09-179333.View ArticlePubMedGoogle Scholar
- Thakker S, McGehee W, Quismorio FP: Arthropathy associated with factor XIII deficiency. Arthritis Rheum. 1986, 29: 808-811. 10.1002/art.1780290617.View ArticlePubMedGoogle Scholar
- Johansson T, Lisander B, Ivarsson I: Mild hypothermia does not increase blood loss during total hip arthroplasty. Acta Anesthesiol Scand. 1999, 43: 1005-1010. 10.1034/j.1399-6576.1999.431006.x.View ArticleGoogle Scholar
- Ivaskevicius V, Seitz R, Kohler HP, Schroeder V, Muszbek L, Ariens RA, Seifried E, Oldenburg J, Study Group: International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost. 2007, 97: 914-921.PubMedGoogle Scholar
- Gerlach R, Tölle F, Raabe A, Zimmermann M, Siegemund A, Seifert V: Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke. 2002, 33: 1618-1623. 10.1161/01.STR.0000017219.83330.FF.View ArticlePubMedGoogle Scholar
- Korte W: Factor XIII in preoperative coagulation management. Best Pract Res Clin Anaesthesiol. 2010, 24: 85-93. 10.1016/j.bpa.2009.09.011.View ArticlePubMedGoogle Scholar
- Spahn DR, Asmis LM: Excessive perioperative bleeding: are fibrin monomers and factor XIII the missing link?. Anesthesiology. 2009, 110: 212-213.PubMedGoogle Scholar
- Fukue H, Arai M: Factor XIII A subunit deficiency. The Journal of Japanese Society on Thrombosis and Hemostasis. 2001, 12: 66-73. 10.2491/jjsth.12.66.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.